Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-09-19
2006-09-19
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S387300, C514S002600, C435S069700, C435S440000, C424S185100
Reexamination Certificate
active
07109295
ABSTRACT:
The invention is related to a fusion polypeptide involving transcription regulation of a target gene. Said fusion polypeptide consists of (i) a zinc finger domain that recognizes and binds to the corresponding nucleic acid recognition sequence in the vicinity of a promoter of the target gene; (ii) a dimerization domain of a tetracycline (tet) repressor which contains a drug (e.g., tetracycline)-dependent switch, and (iii) an accessory domain which alters the expression of the target gene (such as an transcriptional activation or repression domain). This fusion polypeptide can be administered to, or expressed in, a cell harboring the target gene to be regulated.
REFERENCES:
patent: 6136954 (2000-10-01), Bujard et al.
patent: 6271348 (2001-08-01), Bujard et al.
patent: WO 9601313 (1996-01-01), None
Numoto et al. (1999) ZF5, which is a Kruppel-type transcriptional repressor, requires the zinc finger domain for self-association. Biochem. Biophys. Res. Commun. vol. 256, No. 3, pp. 573-578.
Englert, C. (1998) WT1—more than a transcription factor? Trends Biochem. Sci. vol. 23, No. 10, pp. 389-393.
Blau and Rossi, “Tet B or not tet B: Advances in tetracycline-inducible gene expression,”Proc. Natl. Acad. Sci. USA, 96:797-799 (1999).
Deuschle et al., “Tetracycline-Reversible Silencing of Eukaryotic Promoters,”Mol. Cell. Biol., 15(4):1907-1914 (1995).
Forster et al., “Tetracycline-inducible expression systems with reduced basal activity in mammalian cells,”Nucleic Acids Res., 27(2):708-710 (1999).
Looman et al., “KRAB Zinc Finger Proteins: An Analysis of the Molecular Mechanisms Governing Their Increase in Numbers and Complexity During Evolution,”Mol. Biol. Evol., 19(12):2118-2130 (2002).
Maxwell and Maxwell, “Control of parvovirus DNA replication by a tetracycline-regulated repressor,”Gene Ther., 6:309-313 (1999).
Nakayama et al., “Tetracycline-Regulatable System To Tightly Control Gene Expression in the Pathogenic FungusCandida albicans,” Infect. Immun., 68(12):6712-6719 (2000).
Peng et al., “Biochemical Analysis of the Kruppel-associated Box (KRAB) Transcriptional Repression Domain,”J. Biol. Chem., 275(24):18000-18010 (2000).
Ryan et al., “KAP-1 Corepressor Protein Interacts and Colocalizes with Heterochromatic and Euchromatic HP1 Proteins: a Potential Role for Krüppel-Associated Box-Zinc Finger Proteins in Heterochromatin-Mediated Gene Silencing,”Mol. Cell. Biol., 19(6):4366-4378 (1999).
Abraham and Wiederrecht, “Immunopharmacology of rapamycin,” J. Ann. Rev. Immunol. 14:483-510 (1996).
Beerli et al., “Positive and negative regulation of endogenous genes by designed transcription factors,” Proc. Natl. Acad. Sci. USA 97(4):1495-500 (2000).
Beerli et al., “Chemically regulated zinc finger transcription factors,” J. Biol. Chem. 275(42):32617-627 (2000).
Clemons et al., “Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors,” Chem. Biol. 9(1):49-61 (2002).
Coward et al., “4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma,” Proc. Natl. Acad. Sci. USA. 98(15):8880-84 (2001).
Detmar et al., “Increased microvascular density and enhanced leukocyte rolling adhesion in the skin of VEGF transgenic mice,” J. Invest. Dermatol. 111(1):1-6 (1998).
Elrod-Erickson, “Zif268 protein-DNA complex refined at 1.6 {dot over (A)}: a model system for understanding zinc finger-DNA interactions,” Structure 4(10):1171-80 (1996).
Elson et al., “Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha,” Genes Dev. 15(19):2520-32(2001).
Gossen et al., “Transcriptional activation by tetracyclines in mammalian cells,” Science 268(5218):1766-9 (1995).
Hinrichs et al., “Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance,” Science 264(5157):418-20 (1994).
Kim et al., “A 2.2 {dot over (A)} resolution crystal structure of a designed zinc finger protein bound to DNA,” Nat. Struct. Biol. 3(11):940-5 (1996).
Larcher et al., “VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development,” Oncogene 17(3):303-11 (1998).
Liu et al., “Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A,” J. Biol. Chem. 276(14):11323-34 (2001).
Liu et al., “Validated zinc finger protein designs for all 16 GNN DNA triplet targets,” J. Biol. Chem. 277(6):3850-6 (2002).
Orth et al., “Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system,” Nat. Struct. Biol. 7(3):215-19 (2000).
Pabo et al., “Design and selection of novel Cys2His2zinc finger proteins,” Annu. Rev. Biochem. 70:313-40 (2001).
Pomerantz et al., “Structure-based design of transcription factors,” Science 267(5194):93-96 (1995).
Pomerantz, “Structure-based design of a dimeric zinc finger protein,” Biochemistry 37(4):965-70 (1998).
Rebar et al., “Induction of angiogenesis in a mouse model using engineered transcription factors,” Nat. Med. 8(12):1427-32 (2002).
Rivera et al., “A humanized system for pharmacologic control of gene expression,” Nat. Med. 2(9):1028-32 (1996).
Saenger, “The Tetracycline Repressor—A Paradigm for a Biological Switch,” Angew Chem. Int. Ed. Engl. 39(12):2042-2052 (2000).
Stemmer, “Rapid evolution of a protein in vitro by DNA shuffling,” Nature 370(6488):389-91 (1994).
Thurston et al., “Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1,” Science 286(5449):2511-4 (1999).
Urlinger et al., “Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity,” Proc. Natl. Acad. Sci. USA 97(14):7963-8 (2000).
Wolfe et al., “DNA recognition by Cys2His2zinc finger proteins,” Annu. Rev. Biophys. Biomol. Struct. 29:183-212 (2000).
Wolfe et al., “Beyond the “recognition code”: structures of two Cys2His2 zinc finger/TATA box complexes,” Structure (Camb) 9(8):717-23 (2001).
Wolfe et al., “Combining structure-based design with phage display to create new Cys2His2zinc finger dimers,” Structure Fold. Des. 8(7):739-50 (2000).
Xu et al., “A versatile framework for the design of ligand-dependent, transgene-specific transcription factors,” Mol. Ther. 3(2):262-73 (2001).
Ye et al., “Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer,” Science 283(5398):88-91 (1999).
Zhang et al., “Synthetic zinc finger transcription factor action at an endogenous chromosomal site. Activation of the human erythropoietin gene,” J. Biol. Chem. 275(43):33850-60 (2000).
Liu Samuel
University of Massachusetts
Weber Jon
LandOfFree
Zinc finger-based drug-dependent gene regulation system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc finger-based drug-dependent gene regulation system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc finger-based drug-dependent gene regulation system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3551885